The G34R/V point mutation in H3F3A co-segregates with TP53 and ATRX mutations and is frequently associated with MGMT promoter methylation, which is a strong prognostic factor regarding the outcome of adult patients with glioblastoma (GBM) [17,28]. The gene discussed is ATRX; the disease is glioblastoma.